Concentric Analgesics

Focus: Concentric Analgesics is a San Francisco-based biotechnology company focused on drug discovery and development, currently in early-stage clinical development with a concentrated pipeline targeting pain indications.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Concentric Analgesics

AI assessmentNot Hiring

No open roles listed right now. Follow Concentric Analgesics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CA-008

Hallux Valgus Deformity

Phase 1

Clinical Trials (1)

NCT03307837A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity

Phase 1

Help build intelligence for Concentric Analgesics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline in pain management (CA-008) with multiple ongoing trials across Phase 1/2 and Phase 2 stages, offering exposure to clinical development from early through mid-stage programs
Early-stage biotech environment typically offers broader role scope and faster decision-making than larger organizations
Therapeutic area (analgesia/pain) has sustained commercial demand and regulatory pathways are well-established

Watch Out For

Zero active job openings signal minimal hiring activity and possible resource constraints or organizational challenges
Pre-revenue stage with unknown funding history creates uncertainty around runway, financial stability, and long-term career security
Highly concentrated pipeline (single asset CA-008 across multiple indications) with no Phase 3 programs or marketed products limits diversification and near-term commercial catalysts

Generated by Claude from Concentric Analgesics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

CA-008

Postsurgical Pain

Phase 1/2

Clinical Trials (1)

NCT04203537Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)

Phase 1/2

CA-008

Postsurgical Pain

Phase 1/2

Clinical Trials (1)

NCT04774328Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Phase 1/2